News releases
Date
Language

Type of release


Download

Full announcement
May 02, 2012

Novo Nordisk A/S : Novo Nordisk A/S purchases B shares worth DKK 4.2 billion from Novo A/S as part of the ongoing share repurchase programme

Novo Nordisk A/S has today entered into an agreement to purchase 5,100,000 B shares (nominal DKK 1) of a value of DKK 4.2 billion from Novo A/S as part of the ongoing DKK 12.0 billion share repurchase programme for a 12 month period beginning 2 February 2012. The transaction price is set to DKK 823.11 per share and has been calculated as the average market price from 27 April to 1 May in the open trading window following the announcement of Novo Nordisk's financial results for the first quarter of 2012.

Further information on Novo Nordisk A/S please contact:

Media: Investors:
Outside North America: Kasper Roseeuw Poulsen
Anne Margrethe Hauge Tel: (+45) 4442 4303
Tel: (+45) 4442 3450 krop@novonordisk.com
amhg@novonordisk.com
Frank Daniel Mersebach
Tel: (+45) 4442 0604
fdni@novonordisk.com
Lars Borup Jacobsen
Tel: (+45) 3075 3479
lbpj@novonordisk.com
In North America:
Ken Inchausti Jannick Lindegaard
Tel: (+1) 609 514 8316 Tel: (+1) 609 786 4575
kiau@novonordisk.com jlis@novonordisk.com

Further information on Novo A/S please contact:

Media:

Henrik Gürtler, CEO
Tel: (+45) 3527 6575

Thorkil Kastberg Christensen, CFO
Tel: (+45) 3527 6592

Company Announcement No 31 / 2012